120 related articles for article (PubMed ID: 18534961)
1. Coincidential successful treatment of Jessner-Kanof disease with chemotherapy.
Ardavanis A; Orphanos G; Skafida S; Basioukas S; Rigatos G
Ann Oncol; 2008 Jul; 19(7):1360-1361. PubMed ID: 18534961
[No Abstract] [Full Text] [Related]
2. Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
Joaquim AI; Sagarra AJ; Ramos CD; Coudry R; Sagarra RA; Camargo EE
Clin Nucl Med; 1997 Sep; 22(9):638-40. PubMed ID: 9298303
[No Abstract] [Full Text] [Related]
3. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
4. Serial integrated (18)F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma.
Beresford M; Lyburn I; Sanghera B; Makris A; Wong WL
Breast J; 2007; 13(4):424-5. PubMed ID: 17593051
[No Abstract] [Full Text] [Related]
5. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
6. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
Rodenhuis S; Richel DJ; van der Wall E; Schornagel JH; Baars JW; Koning CC; Peterse JL; Borger JH; Nooijen WJ; Bakx R; Dalesio O; Rutgers E
Lancet; 1998 Aug; 352(9127):515-21. PubMed ID: 9716055
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].
Ost E; Illiger HJ
Strahlenther Onkol; 2002 Jan; 178(1):54-5. PubMed ID: 11977396
[No Abstract] [Full Text] [Related]
8. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
9. Parotid gland metastasis of a breast cancer.
Perez-Fidalgo JA; Chirivella I; Laforga J; Colio JM; Blanes MD; Baydal R; Roselló S; De-la-Morena E; Lluch A
Clin Transl Oncol; 2007 Apr; 9(4):264-5. PubMed ID: 17462982
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minor.
Del Mastro L; Venturini M; Costantini M; Garrone O; Sertoli MR; Bertelli G; Machì AM; Rosso R
J Natl Cancer Inst; 1997 Mar; 89(6):455-6. PubMed ID: 9091649
[No Abstract] [Full Text] [Related]
11. Success of neoadjuvant chemotherapy in conversion of mastectomy to breast conservation surgery.
Kaufmann P; Dauphine CE; Vargas MP; Burla ML; Isaac NM; Gonzalez KD; Rosing D; Vargas HI
Am Surg; 2006 Oct; 72(10):935-8. PubMed ID: 17058739
[TBL] [Abstract][Full Text] [Related]
12. An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.
Bonnefoi H; Biganzoli L; Cufer T; Mauriac L; Hamilton A; Schaefer P; Piccart M
Breast Cancer Res Treat; 2001 Nov; 70(1):55-63. PubMed ID: 11768362
[TBL] [Abstract][Full Text] [Related]
13. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
[TBL] [Abstract][Full Text] [Related]
14. Infiltrating ductal carcinoma and synchronous malignant phyllodes tumour. Diagnostic and therapeutic approaches.
Merck B; Cansado Martínez P; Pérez Ramos M; Martínez Banaclocha N; Lacueva Gómez FJ; Calpena R
Clin Transl Oncol; 2006 Nov; 8(11):830-2. PubMed ID: 17134973
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.
Mombelli S; Kwiatkowski F; Abrial C; Wang-Lopez Q; de Boissieu P; Garbar C; Bensussan A; Curé H
Oncology; 2015; 88(5):261-72. PubMed ID: 25573741
[TBL] [Abstract][Full Text] [Related]
16. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC
Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898
[TBL] [Abstract][Full Text] [Related]
17. Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer.
Moyses B; Haegele P; Rodier JF; Lehmann S; Petit T; Velten M; Schraub S
Clin Breast Cancer; 2002 Jan; 2(4):304-10. PubMed ID: 11899363
[TBL] [Abstract][Full Text] [Related]
18. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer].
Wang B; Fu JF; Hong ZW
Ai Zheng; 2009 Mar; 28(3):292-6. PubMed ID: 19619445
[TBL] [Abstract][Full Text] [Related]
20. [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
Iida S; Furukawa K; Yokoyama T; Yanagihara K; Iwasaki R; Noguchi T; Tsuchiya S; Sugisaki Y; Naito Z; Tajiri T
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1697-700. PubMed ID: 17940394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
